21st May 2007 11:09
Advanced Medical Solutions Grp PLC21 May 2007 TR-1: Notification of major interests in shares 1. Identity of the issuer or the underlying issuer of Advanced Medical Solutions Group Plcexisting shares to which voting rights are attached 2. Reason for the notification (please tick the appropriate box or boxes) An acquisition or disposal of voting rights x An acquisition or disposal of financial instruments which may result in theacquisition of shares already issued to which voting rights are attached An event changing the breakdown of voting rights Other (please specify): 3. Full name of person(s) subject to the AXA S.A., 25 Avenue Matignon, 75008 Paris and itsnotification obligation: group of companies 4. Full name of shareholder(s) (if differentfrom 3.): 5. Date of the transaction (and date on which 16 May 2007the threshold is crossed or reached ifdifferent): 6. Date on which issuer notified: 18 May 2007 7. Threshold(s) that is/are crossed or reached: 12% 8. Notified details: A: Voting rights attached to shares Class/type of Situation previous to Resulting situation after the triggering transaction(i)shares the Triggering transaction if possible Number of Number of Number of Number of voting rights % of voting rightsusing the ISIN Shares Voting sharesCODE Rights Direct Indirect Direct Indirect GB0004536594 17,162,661 17,162,661 315,161 315,161 17,197,500 0.22 12.05 B: Financial Instruments Resulting situation after the triggering transactio Type of financial Expiration date Exercise/ Conversion Number of voting rights % ofinstrument Period/ Date that may be acquired if voting the instrument is rights exercised/ converted. - Total (A+B) Number of voting rights % of voting rights 17,512,661 12.27% 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: Name of Company / Fund Number of Shares % of issued share capital Sun Life Pensions Management Ltd 15,161 0.01062%Direct Sun Life Pensions Management Ltd 300,000 0.21013%Direct AXA Framlington Framlington Innovative Growth 10,000,000 7.00450% Indirect AXA Framlington Health 1,000,000 0.70045%Indirect AXA Framlington Biotech 2,550,000 1.78615%Indirect Framlington onshore private clients 2,447,500 1.71435%Indirect AWF Framlington Health 1,200,000 0.84054%Indirect Total Direct 315,161 0.22075%Total Indirect 17,197,500 12.04598% TOTAL 17,512,661 12.26674% Proxy Voting: 10. Name of the proxy holder: 11. Number of voting rights proxy holder will cease to hold: 12. Date on which proxy holder will cease to hold votingrights: 13. Additional information: 14. Contact name: Mary Tavener 15. Contact telephone number: +44 (0)1606 545509 -------------------------- This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Advanced Medical Solutions Group